The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Are the β-Cell Signaling Molecules Malonyl-CoA and Cystolic Long-Chain Acyl-CoA Implicated in Multiple Tissue Defects of Obesity and NIDDM?
Abstract
Widely held theories of the pathogenesis of obesity-associated NIDDM have implicated apparently incompatible events as seminal: 1) insulin resistance in muscle, 2) abnormal secretion of insulin, and 3) increases in intra-abdominal fat. Altered circulating or tissue lipids are characteristic features of obesity and NIDDM. The etiology of these defectss is not known. In this perspective, we propose that the same metabolic events, elevated malonyl-CoA and long-chain acyl-CoA (LC-CoA), in various tissues mediate, in part, the pleiotropic alterations characteristic of obesity and NIDDM. We review the evidence in support of the emerging concept that malonyl-CoA and LC-CoA act as metabolic coupling factors in β-cell signal transduction, linking fuel metabolism to insulin secretion. We suggest that acetyl-CoA carboxylase, which synthesizes malonyl-CoA, a “signal of plenty,” and carnitine palmitoyl transferase 1, which is regulated by it, may perform as fuel sensors in the β-cell, integrating the concentrations of all circulating fuel stimuli in the β-cell as well as in muscle, liver, and adipose tissue. The target effectors of LC-CoA may include protein kinase C sub-types, complex lipid formation, genes encoding metabolic enzymes or transduction factors, and protein acylation. We support the concept that only under conditions in which both glucose and lipids are plentiful will the metabolic abnormality, which may be termed glucolipoxia, become apparent. If our hypothesis is correct that common signaling abnormalities in the metabolism of malonyl-CoA and LC-CoA contribute to altered insulin release and sensitivity, it offers a novel explanation for the presence of variable combinations of these defects in individuals with differing genetic backgrounds and for the fact that it has been difficult to determine whether one or the other is the primary event.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Glucose induces closure of single potassium channels in isolated rat pancreatic β-cells
Ashcroft, F. M., Harrison, D. E., & Ashcroft, S. J. H. (1984) · Nature · doi:10.1038/312446a0 · Cited by 1,113 · cited 2×
“(3-cells possess a unique stimulus-response coupling system that requires that the fuel stimulus be metabolized to initiate membrane electrical events and then secretion (22,23).”
BackgroundA possible role for malonyl-CoA in the regulation of hepatic fatty acid oxidation and ketogenesis.
McGarry, J. D., Mannaerts, G. P., & Foster, D. W. (1977) · Journal of Clinical Investigation · doi:10.1172/jci108764 · Cited by 736
What if Minkowski Had Been Ageusic? An Alternative Angle on Diabetes
McGarry, J. D. (1992) · Science · doi:10.1126/science.1439783 · Cited by 657
Abnormal patterns of insulin secretion in non-insulin-dependent diabetes mellitus.
Polonsky, K. S., Given, B. D., Hirsch, L. J., Tillil, H., Shapiro, E. T., Beebe, C., Frank, B. H., Galloway, J. A., & Van Cauter, E. (1988) · New England Journal of Medicine · doi:10.1056/nejm198805123181903 · Cited by 567
Impaired Pulsatile Secretion of Insulin in Relatives of Patients with Non-Insulin-Dependent Diabetes
O'Rahilly, S., Turner, R. C., & Matthews, D. R. (1988) · New England Journal of Medicine · doi:10.1056/nejm198805123181902 · Cited by 540
Gembal, M., Gilon, P., & Henquin, J. C. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115714 · Cited by 494
Mechanism of glucose-induced insulin secretion.
Hedeskov, C. J. (1980) · Physiological Reviews · doi:10.1152/physrev.1980.60.2.442 · Cited by 435
Glucose dependent K+-channels in pancreatic?-cells are regulated by intracellular ATP
Rorsman, P., & Trube, G. (1985) · Pfl�gers Archiv European Journal of Physiology · doi:10.1007/bf00595682 · Cited by 387
The metabolism of lipids in mouse pancreatic islets. The oxidation of fatty acids and ketone bodies
Berne, C. (1975) · Biochemical Journal · doi:10.1042/bj1520661 · Cited by 77
Cited by
Type 2 diabetes as an inflammatory disease
Donath, M. Y., & Shoelson, S. E. (2011) · Nature Reviews Immunology · doi:10.1038/nri2925 · Cited by 3,737
Islet cell failure in type 2 diabetes
Prentki, M. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29103 · Cited by 1,690
Self-citationMcGarry, J. D. (2002) · Diabetes · doi:10.2337/diabetes.51.1.7 · Cited by 1,435
Pathogenesis of type 2 diabetes mellitus
DeFronzo, R. A. (2004) · Medical Clinics of North America · doi:10.1016/j.mcna.2004.04.013 · Cited by 1,342
Lewis, G. F., Carpentier, A., Adeli, K., & Giacca, A. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.2.0461 · Cited by 1,333
Five stages of evolving beta-cell dysfunction during progression to diabetes
Weir, G. C., & Bonner-Weir, S. (2004) · Diabetes · doi:10.2337/diabetes.53.suppl_3.s16 · Cited by 1,126
Glucolipotoxicity: fuel excess and β-cell dysfunction
Poitout, V., & Robertson, R. P. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0023 · Cited by 1,092
Robertson, R. P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.r400019200 · Cited by 1,078
AMP-activated protein kinase, a metabolic master switch: possible roles in Type 2 diabetes
Winder, W. W., & Hardie, D. G. (1999) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1999.277.1.e1 · Cited by 1,000
β-Cell Glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes.
Robertson, R. P., Harmon, J., Tran, P. O. T., & Poitout, V. (2004) · Diabetes · doi:10.2337/diabetes.53.2007.s119 · Cited by 914
Mitochondrial Dysfunction in Atherosclerosis
Madamanchi, N. R., & Runge, M. S. (2007) · Circulation Research · doi:10.1161/01.res.0000258450.44413.96 · Cited by 797
Poitout, V., & Robertson, R. P. (2002) · Endocrinology · doi:10.1210/endo.143.2.8623 · Cited by 743
β-Cell Failure in Diabetes and Preservation by Clinical Treatment
Wajchenberg, B. L. (2007) · Endocrine Reviews · doi:10.1210/10.1210/er.2006-0038 · Cited by 714
Role of long-chain fatty acyl-CoA esters in the regulation of metabolism and in cell signalling
FÆRGEMAN, N. J., & KNUDSEN, J. (1997) · Biochemical Journal · doi:10.1042/bj3230001 · Cited by 685
Bays, H., Mandarino, L., & DeFronzo, R. A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030723 · Cited by 664
Malonyl-CoA, fuel sensing, and insulin resistance
Ruderman, N. B., Saha, A. K., Vavvas, D., & Witters, L. A. (1999) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1999.276.1.e1 · Cited by 650
Free Fatty Acids and Pathogenesis of Type 2 Diabetes Mellitus
BERGMAN, R., & ADER, M. (2000) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(00)00323-4 · Cited by 622
Boden, G., Lebed, B., Schatz, M., Homko, C., & Lemieux, S. (2001) · Diabetes · doi:10.2337/diabetes.50.7.1612 · Cited by 597
Saturated Fatty Acids Synergize with Elevated Glucose to Cause Pancreatic β-Cell Death
El-Assaad, W., Buteau, J., Peyot, M.-L., Nolan, C., Roduit, R., Hardy, S., Joly, E., Dbaibo, G., Rosenberg, L., & Prentki, M. (2003) · Endocrinology · doi:10.1210/en.2003-0410 · Cited by 587
Self-citationFatty acids, lipotoxicity and insulin secretion
McGarry, J. D., & Dobbins, R. L. (1999) · Diabetologia · doi:10.1007/s001250051130 · Cited by 552
Beta-cell adaptation and decompensation during the progression of diabetes
Weir, G. C., Laybutt, D. R., Kaneto, H., Bonner-Weir, S., & Sharma, A. (2001) · Diabetes · doi:10.2337/diabetes.50.2007.s154 · Cited by 462
AMP kinase and malonyl-CoA: targets for therapy of the metabolic syndrome
Ruderman, N., & Prentki, M. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1344 · Cited by 451
Self-citationLeptin Impairs Metabolic Actions of Insulin in Isolated Rat Adipocytes
Müller, G., Ertl, J., Gerl, M., & Preibisch, G. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.16.10585 · Cited by 450
Acyl-CoA Metabolism and Partitioning
Grevengoed, T. J., Klett, E. L., & Coleman, R. A. (2014) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071813-105541 · Cited by 440
Malonyl-CoA Signaling, Lipid Partitioning, and Glucolipotoxicity
Prentki, M., Joly, E., El-Assaad, W., & Roduit, R. (2002) · Diabetes · doi:10.2337/diabetes.51.2007.s405 · Cited by 431
Self-citationRecent Insights Into Mechanisms of β-Cell Lipo- and Glucolipotoxicity in Type 2 Diabetes
Lytrivi, M., Castell, A.-L., Poitout, V., & Cnop, M. (2020) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.09.016 · Cited by 408
Fatty Acid Signaling in the β-Cell and Insulin Secretion
Nolan, C. J., Madiraju, M. S. R., Delghingaro-Augusto, V., Peyot, M.-L., & Prentki, M. (2006) · Diabetes · doi:10.2337/db06-s003 · Cited by 403
Self-citationGlucolipotoxicity of the pancreatic beta cell
Poitout, V., Amyot, J., Semache, M., Zarrouki, B., Hagman, D., & Fontés, G. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.08.006 · Cited by 382
Metabolic Syndrome Pathophysiology and Predisposing Factors
Bovolini, A., Garcia, J., Andrade, M. A., & Duarte, J. A. (2021) · International Journal of Sports Medicine · doi:10.1055/a-1263-0898 · Cited by 385
Glucagon-like peptide-1 prevents beta cell glucolipotoxicity
Joly, E., Prentki, M., Buteau, J., El-Assaad, W., Rhodes, C. J., & Rosenberg, L. (2004) · Diabetologia · doi:10.1007/s00125-004-1379-6 · Cited by 337
Self-citationLeptin selectively decreases visceral adiposity and enhances insulin action
Barzilai, N., Wang, J., Massilon, D., Vuguin, P., Hawkins, M., & Rossetti, L. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119865 · Cited by 335
Stoddart, L. A., Smith, N. J., & Milligan, G. (2008) · Pharmacological Reviews · doi:10.1124/pr.108.00802 · Cited by 334
Roles of 5′-AMP-activated protein kinase (AMPK) in mammalian glucose homoeostasis
RUTTER, G. A., da SILVA XAVIER, G., & LECLERC, I. (2003) · Biochemical Journal · doi:10.1042/bj20030048 · Cited by 328
Glycerolipid Metabolism and Signaling in Health and Disease
Prentki, M., & Madiraju, S. R. M. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0007 · Cited by 326
Self-citationImproved Glucose and Lipid Metabolism in Genetically Obese Mice Lacking aP2
Uysal, K. T., Scheja, L., Wiesbrock, S. M., Bonner‐Weir, S., & Hotamışlıgil, G. S. (2000) · Endocrinology · doi:10.1210/en.141.9.3388 · Cited by 324
Briaud, I., Harmon, J. S., Kelpe, C. L., Segu, V. B. G., & Poitout, V. (2001) · Diabetes · doi:10.2337/diabetes.50.2.315 · Cited by 316
Mobilisation of triacylglycerol stores
Gibbons, G. F., Islam, K., & Pease, R. J. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(99)00182-1 · Cited by 297
Clarke, S. D. (2000) · British Journal of Nutrition · doi:10.1017/s0007114500000969 · Cited by 294
Hyperinsulinism in Infancy: From Basic Science to Clinical Disease
DUNNE, M. J., COSGROVE, K. E., SHEPHERD, R. M., AYNSLEY-GREEN, A., & LINDLEY, K. J. (2004) · Physiological Reviews · doi:10.1152/physrev.00022.2003 · Cited by 294
Corkey, B. E. (2012) · Diabetes · doi:10.2337/db11-1483 · Cited by 285
Self-citationLewin, T. M., Kim, J.-H., Granger, D. A., Vance, J. E., & Coleman, R. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102036200 · Cited by 284
Farfari, S., Schulz, V, Corkey, B., & Prentki, M. (2000) · Diabetes · doi:10.2337/diabetes.49.5.718 · Cited by 266
Self-citationMinireview: Malonyl CoA, AMP-Activated Protein Kinase, and Adiposity
Ruderman, N. B., Saha, A. K., & Kraegen, E. W. (2003) · Endocrinology · doi:10.1210/en.2003-0849 · Cited by 266
Chemistry and Biochemistry of (−)-Hydroxycitric Acid from Garcinia
Jena, B. S., Jayaprakasha, G. K., Singh, R. P., & Sakariah, K. K. (2002) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf010753k · Cited by 258
Fatty acid metabolism and insulin secretion in pancreatic beta cells
Yaney, G. C., & Corkey, B. E. (2003) · Diabetologia · doi:10.1007/s00125-003-1207-4 · Cited by 255
Self-citationAcute enhancement of insulin secretion by FFA in humans is lost with prolonged FFA elevation
Carpentier, A., Mittelman, S. D., Lamarche, B., Bergman, R. N., Giacca, A., & Lewis, G. F. (1999) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1999.276.6.e1055 · Cited by 254
Expression and Characterization of Recombinant Rat Acyl-CoA Synthetases 1, 4, and 5
Kim, J.-H., Lewin, T. M., & Coleman, R. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010793200 · Cited by 252
Dysfunctional fat cells, lipotoxicity and type 2 diabetes
Defronzo, R. A. (2004) · International Journal of Clinical Practice · doi:10.1111/j.1368-504x.2004.00389.x · Cited by 236
Uncoupling Protein 2 Knockout Mice Have Enhanced Insulin Secretory Capacity After a High-Fat Diet
Joseph, J. W., Koshkin, V., Zhang, C.-Y., Wang, J., Lowell, B. B., Chan, C. B., & Wheeler, M. B. (2002) · Diabetes · doi:10.2337/diabetes.51.11.3211 · Cited by 220
Blaak, E. E., Wagenmakers, A. J. M., Glatz, J. F. C., Wolffenbuttel, B. H. R., Kemerink, G. J., Langenberg, C. J. M., Heidendal, G. A. K., & Saris, W. H. M. (2000) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2000.279.1.e146 · Cited by 140
Boucher, A., Lu, D., Burgess, S. C., Telemaque-Potts, S., Jensen, M. V., Mulder, H., Wang, M.-Y., Unger, R. H., Sherry, A. D., & Newgard, C. B. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401167200 · Cited by 136
Mechanism of Cloned ATP-sensitive Potassium Channel Activation by Oleoyl-CoA
Gribble, F. M., Proks, P., Corkey, B. E., & Ashcroft, F. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.41.26383 · Cited by 133
Self-citationMensink, M., Blaak, E. E., van Baak, M. A., Wagenmakers, A. J. M., & Saris, W. H. M. (2001) · Diabetes · doi:10.2337/diabetes.50.11.2548 · Cited by 128
Chronic Stress and Diabetes Mellitus: Interwoven Pathologies
Sharma, V. K., & Singh, T. G. (2020) · Current Diabetes Reviews · doi:10.2174/1573399815666191111152248 · Cited by 116
β-Cell deterioration during diabetes: what’s in the gun?
Robertson, R. P. (2009) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2009.05.004 · Cited by 93
Olofsson, C. S., Salehi, A., Holm, C., & Rorsman, P. (2004) · The Journal of Physiology · doi:10.1113/jphysiol.2004.066258 · Cited by 88
“The nature of this signal is as yet undetermined but among suggested candidates are malonyl-CoA and longchain acyl-CoA (LC-CoA; Prentki & Corkey, 1996) as well as diacylglycerol (Corkey et al. 1989; Alcazar et al. 1997).”
BackgroundOlofsson, C. S., Collins, S., Bengtsson, M., Eliasson, L., Salehi, A., Shimomura, K., Tarasov, A., Holm, C., Ashcroft, F., & Rorsman, P. (2007) · Diabetes · doi:10.2337/db06-1150 · Cited by 87
Protection of INS-1 cells from free fatty acid-induced apoptosis by targeting hOGG1 to mitochondria.
Rachek, L. I., Thornley, N. P., Grishko, V. I., LeDoux, S. P., & Wilson, G. L. (2006) · Diabetes · doi:10.2337/diabetes.55.04.06.db05-0865 · Cited by 81
Patterson, S., Flatt, P. R., Brennan, L., Newsholme, P., & McClenaghan, N. H. (2006) · Journal of Endocrinology · doi:10.1677/joe.1.06537 · Cited by 63
“Prolonged exposure to high plasma lipid concentrations also exerts toxic effects on pancreatic -cells (Prentki & Corkey 1996), partly through the accumulation of intracellular triacylglycerol (steatosis) (Unger 1995, Dixon et al. 2004).”
Metabolic Syndrome: Adenosine Monophosphate‐activated Protein Kinase and Malonyl Coenzyme A
Ruderman, N. B., & Saha, A. K. (2006) · Obesity · doi:10.1038/oby.2006.279 · Cited by 62
Delghingaro-Augusto, V., Nolan, C. J., Gupta, D., Jetton, T. L., Latour, M. G., Peshavaria, M., Madiraju, S. R. M., Joly, É., Peyot, M.-L., Prentki, M., et al. (2009) · Diabetologia · doi:10.1007/s00125-009-1317-8 · Cited by 57
Self-citationMiyazaki, Y., De Filippis, E., Bajaj, M., Wajcberg, E., Glass, L., Triplitt, C., Cersosimo, E., Mandarino, L. J., & Defronzo, R. A. (2005) · The British Journal of Diabetes & Vascular Disease · doi:10.1177/14746514050050010601 · Cited by 18
Metadata
- Authors
- Prentki, M., & Corkey, B. E.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 1996-03-01
- Volume
- 45
- Issue
- 3
- Pages
- 273-283
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2039531356
- Cited by
- 469
- References
- 9
- FWCI
- 32.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.